The Prevalence and Clinical Characteristic of Invasive Fungal Disease in Pediatric Oncology Setting with Febrile Neutropenia

Not Applicable

Completed

• Conditions: Pediatric OncologyFebrile neutropeniaInvasive fungal disease; Pediatric Oncology; Febrile neutropenia; Invasive fungal disease

• Registration Number: TCTR20190811004
• Lead Sponsor: Office of Research and Development, Phramongkutklao Hospital and College of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-04-20
• Study Start: 2019-08-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Pediatric oncology patients with febrile neutropenia who were treated at pediatric department, Phramongkutklao Hospital

Exclusion Criteria

Pediatric oncology patients who had not met criteria of febrile neutropenia (fever without neutropenia)
Pediatric oncology patients with febrile neutropenia who had been diagnosed with invasive fungal infection before enrolling to the study

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of invasive fungal disease in pediatric oncology with febrile neutropenia 1 years Descriptive statistics and chi&#45;squared test with p&#45;value < 0.05

Secondary Outcome Measures

Name	Time	Method
Risk factors of invasive fungal disease in pediatric oncology with febrile neutropenia 1 years Descriptive statistics and chi&#45;squared test with p&#45;value < 0.05 ,Clinical characteristics of invasive fungal disease in pediatric oncology with febrile neutropenia 1 years Descriptive statistics and chi&#45;squared test with p&#45;value < 0.05 ,Laboratory and imaging of invasive fungal disease in pediatric oncology with febrile neutropenia 1 years Descriptive statistics and chi&#45;squared test with p&#45;value < 0.05